Suppr超能文献

少突胶质细胞瘤的切除范围与生存:一项基于美国人群的研究。

Extent of resection and survival for oligodendroglioma: a U.S. population-based study.

机构信息

Department of Radiation Oncology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, 622 West 168th Street, BNH B011, New York, NY, 10032, USA.

Department of Neurological Surgery, NewYork-Presbyterian Hospital / Weill Cornell Medical Center, 525 E 68th Street, New York, NY, 10065, USA.

出版信息

J Neurooncol. 2019 Sep;144(3):591-601. doi: 10.1007/s11060-019-03261-5. Epub 2019 Aug 12.

Abstract

BACKGROUND

National guidelines recommend maximal safe resection of low-grade and high-grade oligodendrogliomas. However, there is no level 1 evidence to support these guidelines, and recent retrospective studies on the topic have yielded mixed results.

OBJECTIVE

To assess the association between extent of resection (EOR) and survival for oligodendrogliomas in the general U.S.

METHODS

Cases diagnosed between 2004 and 2013 were selected from the Surveillance, Epidemiology, and End-Results (SEER) Program and retrospectively analyzed for treatment, prognostic factors, and survival times. Cases that did not undergo tumor de-bulking surgery (e.g. no surgery or biopsy alone) were compared to subtotal resection (resection) and gross-total resection (GTR). The primary end-points were overall survival (OS) and cause-specific survival (CSS). An external validation cohort with 1p/19q-codeleted tumors was creating using the TCGA and GSE16011 datasets.

RESULTS

3135 Cases were included in the final analysis. The 75% survival time (75ST) and 5-year survival rates were 47 months and 70.8%, respectively. Subtotal resection (STR, 75ST = 50 months) and GTR (75ST = 61 months) were associated with improved survival times compared to cases that did not undergo surgical debulking (75ST = 20 months, P < 0.001 for both), with reduced hazard ratios (HRs) after controlling for other factors (HR 0.81 [0.68-0.97] and HR 0.65 [0.54-0.79], respectively). GTR was associated with improved OS in both low-grade and anaplastic oligodendroglioma subgroups (HR 0.74 [0.58-0.95], HR 0.60 [0.44-0.82], respectively) while STR fell short of significance in the subgroup analysis. All findings were corroborated by multivariable analysis of CSS and externally validated in a cohort of patients with 1p19q-codeleted tumors.

CONCLUSION

Greater EOR is associated with improved survival in oligodendrogliomas. Our findings in this U.S. population-based cohort support national guidelines.

摘要

背景

国家指南建议最大限度地安全切除低级别和高级别少突胶质细胞瘤。然而,这些指南没有 1 级证据支持,最近关于这个主题的回顾性研究结果不一。

目的

评估在美国一般人群中,切除范围(EOR)与少突胶质细胞瘤生存之间的关系。

方法

从监测、流行病学和最终结果(SEER)计划中选择 2004 年至 2013 年期间诊断的病例,并对其治疗、预后因素和生存时间进行回顾性分析。未进行肿瘤减瘤手术(如无手术或仅活检)的病例与次全切除术(切除)和大体全切除术(GTR)进行比较。主要终点是总生存期(OS)和特定原因生存期(CSS)。使用 TCGA 和 GSE16011 数据集创建了一个 1p/19q 缺失肿瘤的外部验证队列。

结果

3135 例病例纳入最终分析。75%生存时间(75ST)和 5 年生存率分别为 47 个月和 70.8%。与未行手术减瘤的病例相比,次全切除术(STR,75ST=50 个月)和 GTR(75ST=61 个月)与生存时间的改善相关(P<0.001),且在控制其他因素后危险比(HR)降低(HR 0.81[0.68-0.97]和 HR 0.65[0.54-0.79])。GTR 与低级别和间变性少突胶质细胞瘤亚组的 OS 改善相关(HR 0.74[0.58-0.95],HR 0.60[0.44-0.82]),而 STR 在亚组分析中未达到显著水平。所有发现均通过 CSS 的多变量分析得到证实,并在 1p19q 缺失肿瘤患者队列中得到外部验证。

结论

更大的 EOR 与少突胶质细胞瘤的生存改善相关。我们在美国人群队列中的发现支持国家指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验